Our Master of Science degree in Biomedical and Translational Science (MS-BATS) is an exciting clinical research training program offered by the School of Medicine at UC Irvine. It is a flexible interdisciplinary clinical research program aimed at junior faculty in clinical departments, fellows, residents, fourth-year medical students, physicians and others with a solid basic science foundation who are interested in developing the skills needed to conduct, interpret, evaluate and apply clinical research.
This degree program is also appropriate for those with doctoral preparation in other academic disciplines who are interested in conducting clinical research. The recent growing interest in evidence-based medicine, comparative effectiveness research and the science of quality assessment and improvement, makes this MS-BATS program particularly timely.
Interested graduate students wishing to apply for the Fall 2013 entrance into the program will need to apply by either January 15, 2013 (for those wanting an admission decision prior to April 5th); or apply by March 18, 2013 (for those wanting an admission decision prior to June 1st).
The sections below offer additional information and resources about the MS program in Biomedical and Translational Science:
For questions regarding the MS-BATS degree program, please contact Armando Villalpando via email or by phone at: 949.824.8848.
Applicants for Fall 2013 entry should apply online by either Jan. 15, 2013 (for those wanting an admission decision prior to April 5) or apply by March 18, 2013 (for those wanting an admission decision prior to June 1). When completing your online application for graduate admissions, you will be asked to complete a section regarding “Degree Program” information. Please follow the directions below to insure a successful application to the MS degree program in Biomedical and Translational Science:
|School/Department:||Choose “School of Medicine” from the drop-down menu|
|Major/Degree:||Choose “Biomedical & Translational Science M.S. (MS-BATS)”|
|Year and Quarter:||Type in “2013” and mark “Fall”|
|Specific Area of Interest:||Type in Your specific research interest(s): e.g., Device Develop, Drug Develop, IT, Diagnostics, etc.|
Contact us if you have questions. Your paper letters of recommendation that are not submitted via UC Irvine’s online system and your academic transcripts should be mailed to the following address:
Biomedical & Translational Science Degree Program
Attn.: Armando Villalpando, Program Coordinator
School of Medicine
University of California
100 Theory Bldg., Suite # 110
Irvine, California 92697-5800
UC Irvine School of Medicine is developing a comprehensive set of curriculum tracks focusing on the nation's acute need for doctors and scientists who can turn basic and clinical research into improved patient care.
Currently, less than 2 percent of active physicians pursue careers in research. At the same time, the numbers of biomedical discoveries has increased. Consequently, implementing those discoveries into clinical practice has become more difficult.
In the National Institutes of Health’s (NIH) ‘Roadmap’, Dr. Elias Zerhouni called for the transformation of biomedical training and mentoring to promote synergism between physician-investigators and researchers and others trained in basic science and other non-clinical disciplines (see EA Zerhouni, New Eng J Med 2005; 353: 1621-1623).
Dr. Francis Collins, the current director of the NIH, has underscored the importance of translational research, along with the development of comparative-effectiveness research, by placing the issues among the top priorities of the NIH research agenda (see E Dolgin, NatureNews 2009; 460:939).
The faculty leadership at UC Irvine clearly sees the need to expand local training opportunities in clinical research. Related shortages of qualified researchers also must be addressed across a broader range of the biomedical and translational science spectrum, including the study of disease on the molecular level, the conduct of clinical research on human subjects, the synthesis of evidence-based medicine and the development of guidelines to improve clinical practice.
Initially, our MS degree program curriculum will focus on the conduct and interpretation of clinical research and the assessment and improvement of healthcare quality. The long-range expectation is to offer additional fields of emphasis, especially in molecular medicine and population health sciences.
Molecular medicine will focus on the molecular mechanisms and molecular physiology of human disease. Population health sciences will focus on the application of epidemiologic research and research methods to clinical practice.
As the MS-BATS program expands, the faculty expects to offer medical specialty and disease-focused elective concentrations that correspond to medical specialties and sub-specialties throughout the School of Medicine.
The current curriculum design of our MS-BATS degree program is sufficiently flexible to encourage trainees from various departments to enhance their training through electives specific to the content focus of their department or research interests.
While we expect the trainees' research projects will be related to the content focus of the trainee’s department, a multidisciplinary approach will be encouraged by the students' mentoring committee.